A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib

Abroad (travel likely)RecruitingPHASE2

Conditions

Non-Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

    Contact: Study coordinator (Yiruo Zhang)
    Contact: Principal Investigator (Yiruo Zhang)
  • Beijing Cancer Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Jian Fang)
    Contact: Principal Investigator (Jian Fang)
  • Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Jianchun Duan)
    Contact: Principal Investigator (Jianchun Duan)
  • Fujian Cancer Hospital, Fuzhou, Fujian, China

    Contact: Study coordinator (Zhangzhou Huang)
    Contact: Principal Investigator (Zhangzhou Huang)
  • The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

    Contact: Study coordinator (Kejing Tang)
    Contact: Principal Investigator (Tang Tang)
  • Guangxi Medical University Cancer Hospital & Guangxi Cancer Institude, Nanning, Guangxi, China

    Contact: Study coordinator (Shaozhang Zhou)
    Contact: Principal Investigator (Shaozhang Zhou)
  • Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China

    Contact: Study coordinator (Lihua Shang)
    Contact: Principal Investigator (Lihua Shang)
  • Henan Cancer Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Qiming Wang)
    Contact: Principal Investigator (Qiming Wang)
  • Tongji Hospital Tongji Medical College of Hust, Wuhan, Hubei, China

    Contact: Study coordinator (Qian Chu)
    Contact: Principal Investigator (Qian Chu)
  • Hunan Cancer Hospitial, Changsha, Hunan, China

    Contact: Study coordinator (Yongchang Zhang)
    Contact: Principal Investigator (Yongchang Zhang)
  • Zhongda Hospital Southeast University, Nanjing, Jiangsu, China

    Contact: Study coordinator (Shuhua Han)
    Contact: Principal Investigator (Shuhua Han)
  • The First Hospital of China Medical University, Shenyang, Liaoning, China

    Contact: Study coordinator (Mingfang Zhao)
    Contact: Principal Investigator (Mingfang Zhao)
  • Central Hospital Affiliated to Shangdong First Medical University, Jinan, Shangdong, China

    Contact: Study coordinator (Meili Sun)
    Contact: Principal Investigator (Meili Sun)
  • Shanghai Chest Hospital, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Shun Lu)
    Contact: Principal Investigator (Shun Lu)
  • Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Chunxia Su)
    Contact: Principal Investigator (Chunxia Su)
  • The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shanxi, China

    Contact: Study coordinator (Yu Yao)
    Contact: Principal Investigator (Yu Yao)
  • West China Hospital Sichuan University, Chengdu, Sichuan, China

    Contact: Study coordinator (Guowei Che)
    Contact: Principal Investigator (Guowei Che)